Bill Sponsor Says Prospects 'Pretty Good' for Patent-Reform Legislation to Pass This Year

PhRMA has also backed the bill after language was added giving more power to Federal judges to calculate patent-infringement damages by taking into account the various IP components supporting the product at the heart of the case.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories